Head and Neck Cancer Strategies

Brief summary (registry, in English)

The overall aim is to investigate whether genetic and other molecular markers can improve the diagnosis, assessment of treatment response, and detection of recurrence in patients with head and neck cancer. In the longer term, the project aims to contribute to more individualised treatment strategies for our patients. The project will involve comprehensive analyses of tumour tissue and blood, including extensive genetic sequencing and other molecular profiling. Importantly, the research analyses will not have any implications for the clinical management or treatment of the individual patient included in the study.

What you commit to

• Study type: Observational
• Planned participants: 1500
• From 1 Oct 2026 to the primary completion date, 31 Jul 2033
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.